Extracorporeal Liver Support: A Bridge to Somewhere
Abraham J. Matar, Ram Subramanian – 21 July 2021
Assessment of Sarcopenia in Chronic Liver Disease: Indian Perspective
Abhinav Anand, Anoop Saraya – 21 July 2021
Identifying Patients at Highest Risk of Remaining Unvaccinated Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Large Veterans Health Administration Cohort
Nadim Mahmud, Sara E. Chapin, David E. Kaplan, Marina Serper – 21 July 2021
Mitochondrial Hepatopathies
Hana Alharbi, Jessica R.C. Priestley, Benjamin J. Wilkins, Rebecca D. Ganetzky – 21 July 2021
Extracorporeal Liver Support: A Bridge to Somewhere
Abraham J. Matar, Ram Subramanian – 21 July 2021
Impaired Muscle Oxygen Extraction Kinetics in Cirrhosis: Muscle Is a Major Contributor to Impaired Whole‐Body Exercise Capacity
Puneeta Tandon, Corey R. Tomczak, Calvin Kruger, Cynthia Tsien, Mark J. Haykowsky, Richard Thompson – 21 July 2021
Hepatitis C virus in India: Challenges and Successes
Abhinav Anand, Shalimar – 21 July 2021
Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection
Zobair M. Younossi, Maria Stepanova, Brian Lam, Rebecca Cable, Sean Felix, Thomas Jeffers, Elena Younossi, Huong Pham, Manirath Srishord, Patrick Austin, Michael Estep, Kathy Terra, Carey Escheik, Leyla Avila, Pegah Golabi, Andrej Kolacevski, Andrei Racila, Linda Henry, Lynn Gerber – 20 July 2021 – The impact of the coronavirus disease 2019 (COVID‐19) pandemic among patients with chronic liver disease is unknown.
Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD‐L1
Noreen Nog‐Qin Chui, Jacinth Wing‐Sum Cheu, Vincent Wai‐Hin Yuen, David Kung‐Chun Chiu, Chi‐Ching Goh, Derek Lee, Misty Shuo Zhang, Irene Oi‐Lin Ng, Carmen Chak‐Lui Wong – 20 July 2021 – Liver cancers consist primarily of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Immune checkpoint inhibitors have emerged as promising therapeutic agents against liver cancers. Programmed cell death protein 1 (PD‐1) is an immunoinhibitory receptor present on T cells that interacts with its ligand programmed death‐ligand 1 (PD‐L1) found on cancer cells.
COVID‐19 and the Uncovering of Health Care Disparities in the United States, United Kingdom and Canada: Call to Action
Aftab Ala, Julius Wilder, Naudia L. Jonassaint, Carla S. Coffin, Carla Brady, Andrew Reynolds, Michael L. Schilsky – 19 July 2021 – The coronavirus disease 2019 (COVID‐19) pandemic created a crisis that disproportionately affected populations already disadvantaged with respect to access to health care systems and adequate medical care and treatments. Understanding how and where health care disparities are most widespread is an important starting point for exploring opportunities to mitigate such disparities, especially within our patient population with liver disease.